Search results

Our board sets out our strategic priorities and policies. It has 2 sub-committees, the audit and risk assurance committee and the remuneration committee.

NICE's guidance executive is made up of executive directors, guidance centre directors and senior team members.

This document describes a real-world evidence framework that aims to improve the quality of real-world evidence informing our guidance. The framework does not set minimum standards for the acceptability of evidence. The framework is mainly targeted at those developing evidence to inform NICE guidance. It is also relevant to patients, those collecting data, and reviewers of evidence

We're working with colleagues to ensure that virtual wards are used in a way that maximises the value for patients and the NHS.

The EQ-5D is a short questionnaire used to understand how a person’s health affects their quality of life. It is used in health research and to help inform decisions about healthcare treatments.

NICE has implemented new measures to evaluate the cost-effectiveness of medicines, following a policy change that aims to give patients improved access to treatments. This follows the government’s decision to increase the thresholds that NICE can use in technology appraisals to £25,000 to £35,000 per quality-adjusted life year gained.

The NICE commercial liaison team aim to reduce the workload for the NHS and frontline staff by making commercial agreements more straightforward.

Home What NICE does Our research work {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1

Home What NICE does NICE International {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1

Summaries of the best available evidence for selected medicines that are considered to be of significance to the NHS.

The Office for Digital Health strives to accelerate NICE's efforts to deliver innovation to the health and care system.

A joint NICE and NHS England meeting can help to ensure you're ready for NHS patient access and subsequent NICE appraisal

NICE standards for innovators of digital health technologies and NHS commissioners

Get expert advice and support from NICE International, part of the UK's National Institute for Health and Care Excellence, for a project in your country

The Innovative Licensing and Access Pathway (ILAP) is a unique initiative which works with medicine developers early on to help get new medicines to patients faster.